The GLP-1 Side Effect Nobody Warns You About | TUH #291

About this video

In this short solo episode, Brecka traces the development of GLP-1 weight-loss drugs from single- to dual- to triple-receptor generations, citing review literature on their growing potency. His central warning is that, according to Brecka, a substantial share of the weight lost on these drugs in some studies was lean mass rather than fat, which he claims threatens strength, metabolic rate and long-term weight maintenance. He argues prescribers should pair the drugs with attention to protein intake and resistance training, described here at topic level only.

Key takeaways

• Brecka claims newer GLP-1 generations produce larger weight loss by targeting additional receptors.
• Brecka argues what kind of weight is lost matters more than the scale number.
• Brecka claims appetite suppression can undermine protein intake and muscle retention.
• Brecka presents resistance training and adequate protein as non-negotiable companions to GLP-1 use, in his view.

Episode details: published July 30, 2026 · 588.1K views · 6:56 long. Summary written by Self Growth Videos from the episode itself. Gary Brecka is a commercial health figure, not a physician. The claims described are Brecka’s or his guests’, presented for education — not medical advice and not endorsed by Self Growth Videos. Consult a qualified professional before changing your own health practices.

← Previous: Mike Feldstein: The 5 Hidden Air Pollutants in Your Home and How To Fix It! | TUH #290 · Next: BLOOD FILTRATION: START TO FINISH →

All Gary Brecka videos · Gary Brecka profile · The Ultimate Human (official site)